Mary Kay, Inc., in a partnership with the European Society for Dermatological Research, awarded two $20,000 grants to researchers conducting groundbreaking, innovative studies in skin health and skin disease.
These grants were awarded to:
- Dr. Michael Cangkrama, a Senior Scientist in the Department of Biology at the Institute of Molecular Health Sciences, ETH Zürich, who is studying molecular and cellular mechanisms underlying the development and progression of epithelial skin cancers, the most common types of cancer in humans.
- Dr. Clarisse Ganier, a Research Associate at the Center of Gene Therapy and Regenerative Medicine at King’s College London, will work in an international collaborative effort to map all cell types within the human body to generate a comprehensive Skin Cell Atlas.
“Mary Kay is dedicated to advancing skin and nutritional health research globally, and we know this cannot be done alone,” said Dr. Lucy Gildea, Mary Kay Chief Innovation Officer, Product and Science. “Collaboration across industries, academic institutions, and clinicians is critical, which is why we are proud to partner with ESDR to furnish the first-ever Mary Kay-ESDR Skin Health/Skin Disease Research Grants. These grants bring this larger community together for new inspiration for the future, and Mary Kay is proud to be a part of this opportunity. We are excited to see how these recipients bring greater advancements to different aspects of skin health research.”
